Delcath Systems Inc. (DCTH) Insider Trading

Last 12 months

Insiders bought $287k on the open market and sold nothing.

Net open-market

+$287k

4 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

3 / 0

executives and directors

Last open-market buy

Mar 2026

Mar 6, 2026

Get an email when DCTH's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Mar 6	Sandra Pennell Chief Financial Officer	Bought	5,533	$9.04	$50k	7.7%	Form 4
Mar 2	Gerard J Michel CHIEF EXECUTIVE OFFICER	Bought	11,200	$8.96	$100k	3.4%	Form 4
Nov 21, 2025	John Richard Sylvester Director	Bought	4,386	$8.89	$39k	42%	Form 4
Nov 11, 2025	Gerard J Michel CHIEF EXECUTIVE OFFICER	Bought	11,500	$8.53	$98k	3.6%	Form 4

Mar 6
Sandra Pennell
Chief Financial Officer · bought 5,533 at $9.04
$50k
7.7% of stake
Mar 2
Gerard J Michel
CHIEF EXECUTIVE OFFICER · bought 11,200 at $8.96
$100k
3.4% of stake
Nov 21, 2025
John Richard Sylvester
Director · bought 4,386 at $8.89
$39k
42% of stake
Nov 11, 2025
Gerard J Michel
CHIEF EXECUTIVE OFFICER · bought 11,500 at $8.53
$98k
3.6% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch DCTH, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Surgical & Medical Instruments & Apparatus

MHUAFMeihua International Medical Technologies Co., Ltd.

NPCENeuroPace Inc.

LUNGPulmonx Corporation

IRMDIradimed Corp

KMTSKestra Medical Technologies, Ltd.

XTNTXtant Medical Holdings Inc.

TELATela Bio Inc.

SGHTSight Sciences, Inc.

Spot a number that looks wrong? Check it in DCTH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing DCTH

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.